For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of this treatment and Attruby represents a true advancement . These innovative therapies preserve the transthyretin protein, slowing its damaging build-up and lessening the severity of the illness. Individuals are now experiencing positi